Adherence to GOLD guidelines in real-life COPD management in the Puglia region of Italy

References

• FerkolTBSchraufnagelDThe global burden of respiratory diseaseAnn Am Thorac Soc201411340440624673696
   PubMedGoogle Scholar
• ToyELGallagherKFStanleyELThe economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a reviewCOPD2010721422820486821
   PubMedGoogle Scholar
• DonaldsonGCLawMKowlessarBImpact of prolonged exacerbation recovery in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2015192894395026151174
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life inpatients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1998157141814229603117
   PubMed Web of Science ®Google Scholar
• MüllerovaHMaselliDJLocantoreNHospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohortChest20151474999100725356881
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJMartínez-GarcíaMARománSánchezPSevere acute exacerbations and mortality in patients with chronic obstructive pulmonary diseaseThorax2005601192593116055622
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease updated2015 Available from: http://www.msc.es/organizacion/sns/planCalidadSNS/pdf/GOLD_Report_2015_Apr2.pdfAccessed August 1, 2018
   Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• WedzichaJABuhlRLawrenceDYoungDMonotherapy with indacaterol once daily reduces the rate of exacerbations in patients with moderate-to-severe COPD: post-hoc pooled analysis of 6 months data from three large phase III trialsRespir Med2015109110511125433954
   PubMed Web of Science ®Google Scholar
• WedzichaJACalverleyPMSeemungalTAThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med2008177192617916806
   PubMed Web of Science ®Google Scholar
• The Medicines Utilization Monitoring CentreL’uso dei Farmaci in ItaliaRapporto Nazionale Anno 2016RomaAgenzia Italiana del Farmaco2017 National Report on Medicines use in Italy. January–September 2016. Rome: Italian Medicines Agency, 2017. Available from: http://www.agenziafarmaco.gov.it/sites/default/files/Rapporto_OsMed_2016_AIFA.pdfAccessed August 1, 2018 Italian
   Google Scholar
• AscheCVLeaderSPlauschinatCAdherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroidsInt J Chron Obstruct Pulmon Dis2012720120922500120
   PubMed Web of Science ®Google Scholar
• ChiangCHLiuSLChuangCHJhengYHEffects of guideline-oriented pharmacotherapy in patients with newly diagnosed COPD: a prospective studyWien Klin Wochenschr201312513–1435336123817861
   PubMed Web of Science ®Google Scholar
• RocheNLepageTBourcereauJTerriouxPGuidelines versus clinical practice in the treatment of chronic obstructive pulmonary diseaseEur Respir J2001186903.e9011829094
   PubMed Web of Science ®Google Scholar
• MiravitllesMSicrasACrespoCCosts of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care settingTher Adv Respir Dis20137313915023653458
   PubMed Web of Science ®Google Scholar
• ChanKPKoFWChanHSAdherence to a COPD treatment guideline among patients in Hong KongInt J Chron Obstruct Pulmon Dis2017123371337929238182
   PubMed Web of Science ®Google Scholar
• RamseySDSuboptimal medical therapy in COPD: exploring the causes and consequencesChest20001172 suppl33S37S10673472
   PubMed Web of Science ®Google Scholar
• TuranOEmreJCDenizSBaysakATuranPAMiriciAAdherence to current COPD guidelines in TurkeyExpert Opin Pharmacother201617215315826629809
   PubMed Web of Science ®Google Scholar
• CabanaMDRandCSPoweNRWhy don’t physicians follow clinical practice guidelines? A framework for improvementJAMA1999282151458146510535437
   PubMed Web of Science ®Google Scholar
• LucasAESmeenkFWSmeeleIJvan SchayckCPOvertreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory studyFam Pract2008252869118304973
   PubMed Web of Science ®Google Scholar
• DesaluOOOnyedumCCAdeotiAOGuideline-based COPD management in a resource-limited setting – physicians’ understanding, adherence and barriers: a cross-sectional survey of internal and family medicine hospital-based physicians in NigeriaPrim Care Respir J2013221798523443222
   PubMedGoogle Scholar
• SinDDManSFSteroids in COPD: still up in the air?Eur Respir J20103594995120436169
   PubMed Web of Science ®Google Scholar
• KaurIAggarwalBGogtayJUnderstanding perception of chronic obstructive pulmonary disease among general practitioners, physicians, and pulmonologists in India: results from a face-to-face surveyPerspect Clin Res20167210010527141477
   PubMedGoogle Scholar
• HanMKMuellerovaHCurran-EverettDGOLD 2011 disease severity classification in COPD Gene: a prospective cohort studyLancet Respir Med201311435024321803
   PubMed Web of Science ®Google Scholar
• VarkeyJBVarkeyABVarkeyBProphylactic vaccinations in chronic obstructive pulmonary disease: current statusCurr Opin Pulm Med2009152909919532022
   PubMed Web of Science ®Google Scholar
• IversNMGrimshawJMJamtvedtGGrowing literature, stagnant science? Systematic review, meta-regression and cumulative analysis of audit and feedback interventions in health careJ Gen Intern Med201429111534154124965281
   PubMed Web of Science ®Google Scholar
• RobertsCMLopez-CamposJLPozo-RodriguezFHartlSEuropean COPD Audit teamEuropean hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissionsThorax201368121169117123729193
   PubMed Web of Science ®Google Scholar
• Lopez-CamposJLHartlSPozo-RodriguezFRobertsCMVariability of hospital resources for acute care of COPD patients: the European COPD AuditEur Respir J201443375476223988775
   PubMed Web of Science ®Google Scholar
• Pozo-RodriguezFCastro-AcostaAAlvarezCJDeterminants of between-hospital variations in outcomes for patients admitted with COPD exacerbations: findings from a nationwide clinical audit (AUDI-POC) in SpainInt J Clin Pract201569993894725651319
   PubMed Web of Science ®Google Scholar
• VelickovskiFCeccaroniLRocaJClinical Decision Support Systems (CDSS) for preventive management of COPD patientsJ Transl Med201412suppl 2S925471545
   PubMed Web of Science ®Google Scholar
• WeiYFKuoPHTsaiYHFactors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD – subgroup analysis of the Taiwan obstructive lung disease cohortInt J Chron Obstruct Pulmon Dis2015101951195626392770
   PubMed Web of Science ®Google Scholar
• de Miguel-DiezJCarrasco-GarridoPRejas-GutierrezJInappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health statusLung2011189319920621499887
   PubMed Web of Science ®Google Scholar
• WhitePThorntonHPinnockHGeorgopoulouSBoothHPOver-treatment of COPD with inhaled corticosteroids – implications for safety and costs: cross-sectional observational studyPLoS One2013810e7522124194824
   PubMed Web of Science ®Google Scholar
• CorradoARossiAHow far is real life from COPD therapy guidelines? An Italian observational studyRespir Med2012106798999722483189
   PubMed Web of Science ®Google Scholar